Document
IPR2019-00449, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Jan. 28, 2019)
Cite Document
IPR2019-00449, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Jan. 28, 2019)
+ More Snippets
Document
IPR2019-00451, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Jan. 29, 2019)
Cite Document
IPR2019-00451, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Jan. 29, 2019)
+ More Snippets
Document
IPR2019-00451, No. 2026-158 Exhibit - Affidavit of Ronald Figueroa (P.T.A.B. Apr. 28, 2020)
Cite Document
IPR2019-00451, No. 2026-158 Exhibit - Affidavit of Ronald Figueroa (P.T.A.B. Apr. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 2030-154 Exhibit - J Wyse, US Patent No 9,192,570 issued November 24, 2015 (P.T.A.B. Mar. 10, 2020)
Cite Document
IPR2019-00451, No. 2030-154 Exhibit - J Wyse, US Patent No 9,192,570 issued November 24, 2015 (P.T.A.B. Mar. 10, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1070-96 Exhibit - Gizurarson, Patent Application Publication No US 20080275030, Nov 6, 2008 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1070-96 Exhibit - Gizurarson, Patent Application Publication No US 20080275030, Nov 6, 2008 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1119-123 Exhibit - Davis GA, Rudy AC, Archer SA, Wermeling DP, McNamara PJ Effect of fluticasone propionate nasal spray on bioavailability of hydromorphone hydrochlo...
Cite Document
IPR2019-00451, No. 1119-123 Exhibit - Davis GA, Rudy AC, Archer SA, Wermeling DP, McNamara PJ Effect of fluticasone propionate nasal spray on bioavailability of hydromorphone hydrochloride in patient
+ More Snippets
Document
IPR2019-00451, No. 1082-104 Exhibit - Chien, YW, et al, Nasal Systemic Drug Delivery, Chapter 1, Anatomy and Physiology of the Nose, Drugs and the Pharmaceutical Sciences, Vol 39, Marcel ...
Cite Document
IPR2019-00451, No. 1082-104 Exhibit - Chien, YW, et al, Nasal Systemic Drug Delivery, Chapter 1, Anatomy and Physiology of the Nose, Drugs and the Pharmaceutical Sciences, Vol 39, Marcel Decker, 1989
+ More Snippets
Document
IPR2019-00451, No. 1129-130 Exhibit - Burstein AH, Modica R, Hatton M, et al Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration J Clin Pharmacol 1997 37 7...
Cite Document
IPR2019-00451, No. 1129-130 Exhibit - Burstein AH, Modica R, Hatton M, et al Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration J Clin Pharmacol 1997 37 711 718 (P.T.A.
+ More Snippets
Document
IPR2019-00451, No. 1135-134 Exhibit - Greenblatt D, Gan L, Harmatz, et al Pharmacokinetics and pharmacodynamics of single dose triazolam EEG compared with digital symbol substitution te...
Cite Document
IPR2019-00451, No. 1135-134 Exhibit - Greenblatt D, Gan L, Harmatz, et al Pharmacokinetics and pharmacodynamics of single dose triazolam EEG compared with digital symbol substitution test Br J Clin
+ More Snippets
Document
IPR2019-00451, No. 1144-143 Exhibit - Ahmad S, Ellis J, Kamwendo H, et al Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children...
Cite Document
IPR2019-00451, No. 1144-143 Exhibit - Ahmad S, Ellis J, Kamwendo H, et al Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children an open l
+ More Snippets
Document
IPR2019-00451, No. 1109-113 Exhibit - Ericksson K, Kalviainen R Pharmacologic management of convulsive status epilepticus in childhood Expert Rev Neurotherapeutics 2005 5 777 783 (P.T....
Cite Document
IPR2019-00451, No. 1109-113 Exhibit - Ericksson K, Kalviainen R Pharmacologic management of convulsive status epilepticus in childhood Expert Rev Neurotherapeutics 2005 5 777 783 (P.T.A.B. Jan. 28,
+ More Snippets
Document
IPR2019-00451, No. 1101-105 Exhibit - Lowenstein DH, Alldredge BK Status epilepticus N Eng J Med 1998 338 970 976 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1101-105 Exhibit - Lowenstein DH, Alldredge BK Status epilepticus N Eng J Med 1998 338 970 976 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1134-133 Exhibit - Wermeling DP, Miller JL, Archer SM, et al Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administratio...
Cite Document
IPR2019-00451, No. 1134-133 Exhibit - Wermeling DP, Miller JL, Archer SM, et al Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration J Cli
+ More Snippets
Document
IPR2019-00451, No. 1118-122 Exhibit - Constantino HR, Illum L, Brandt G, et al, Intranasal delivery Physicochemical and therapeutic aspects, Intl J Pharmaceutics 2007 337 1 24 (P.T.A.B. Jan...
Cite Document
IPR2019-00451, No. 1118-122 Exhibit - Constantino HR, Illum L, Brandt G, et al, Intranasal delivery Physicochemical and therapeutic aspects, Intl J Pharmaceutics 2007 337 1 24 (P.T.A.B. Jan. 28, 202
+ More Snippets
Document
IPR2019-00451, No. 2015-82 Exhibit - C Cole et al, ¿¿¿Community Survey of Carer¿¿¿s Individual Epilepsy Guidelines IEG for Rescue Medication,¿¿¿ Seizure 18220 224 2009 (P.T.A.B. Nov. 5, 2019...
Cite Document
IPR2019-00451, No. 2015-82 Exhibit - C Cole et al, ¿¿¿Community Survey of Carer¿¿¿s Individual Epilepsy Guidelines IEG for Rescue Medication,¿¿¿ Seizure 18220 224 2009 (P.T.A.B. Nov. 5, 2019)
+ More Snippets